Company Name or Ticker Symbol
Search for other Categories
Goldman Sachs Group Inc  (GS)
Other Ticker:  
    Sector  Financial    Industry Investment Services
   Industry Investment Services
   Sector  Financial
Price: $201.1200 $-1.35 -0.667%
Day's High: $206.45 Week Perf: 1.96 %
Day's Low: $ 200.78 30 Day Perf: 1.32 %
Volume (M): 3,285 52 Wk High: $ 266.49
Volume (M$): $ 660,699 52 Wk Avg: $218.75
Open: $204.88 52 Wk Low: $151.70

 Market Capitalization (Millions $) 77,210
 Shares Outstanding (Millions) 384
 Employees 34,000
 Revenues (TTM) (Millions $) 35,942
 Net Income (TTM) (Millions $) 10,459
 Cash Flow (TTM) (Millions $) 20,496
 Capital Exp. (TTM) (Millions $) 7,982

Goldman Sachs Group Inc
Goldman Sachs is a leading global investment banking, securities and investment management firm that provides a wide range of services worldwide to a substantial and diversified client base. Business Segments Our activities are divided into three segments: • Investment Banking; • Trading and Principal Investments; and • Asset Management and Securities Services.

GS is expected to report next financial results on April 16, 2019.

Goldman Sachs Group Inc's Segments
Total Investment Banking
 Segment    13.23 % of total Revenue
I.B. Financial Advisory
 Segment    13.23 % of total Revenue
I.B. Equity Underwriting
 Segment    9.11 % of total Revenue
I.B. Debt Underwriting
 Segment    9.11 % of total Revenue
Institutional Client Services
 Segment    52.55 % of total Revenue
I.C.S. Fixed Inc. Currency & Commodities
 Segment    23.9 % of total Revenue
I.C.S. Equities
 Segment    28.66 % of total Revenue
Asset Mgmt.
 Segment    23.26 % of total Revenue
Investing & Lending
 Segment    10.96 % of total Revenue
I.L. Equity securities
 Segment    6.05 % of total Revenue
I.L. Debt securities
 Segment    4.91 % of total Revenue
  Company Estimates  
  Revenue Outlook
Goldman Sachs Group Inc does not provide revenue guidance.

Earnings Outlook
Goldman Sachs Group Inc does not provide earnings estimates.

Geographic Revenue Dispersion
United States 58.05 %
Europe 25.81 %
Asia 16.14 %

Goldman Sachs Group Inc's Operating Statistics Decrease / Increase
Money markets (Assets under Mgmt.) in Mill. $ 258,000.00    Money markets (Assets under Mgmt.) in Mill. $ Growth  1.18 % 
Fixed income (Assets under Mgmt.) in Mill. $ 547,000.00    Fixed income (Assets under Mgmt.) in Mill. $ Growth  5.8 % 
Equity (Assets under Mgmt.) in Mill. $ 237,000.00    Equity (Assets under Mgmt.) in Mill. $ Growth  2.16 % 
Alternative investments (Assets under Mgmt.) in Mill. $ 146,000.00    0 % 
Total (Assets under Mgmt.) in Mill. $ 1,188,000.00    Total (Assets under Mgmt.) in Mill. $ Growth  3.3 % 
• View Complete Report

Och-ziff Capital Management Group Llc

Och-ziff Capital Management Group Llc announced forth quarter operating shortfall of $-101.419 millions

Och-ziff Capital Management Group Llc reported disastrous forth quarter, where Sales faded by -60.02 % to $175.22 millions and loss per share has widen to $-0.01, from the same quarter a year ago.

Bank Of Marin Bancorp

Bank Of Marin Bancorp announced forth quarter operating surplus of $12.99 millions

Bank Of Marin Bancorp showed respectable growth in the forth quarter, where earnings jumped by 62.92 % year on year to $0.28 per share and Revenue increased by 23.42 % to $26.70 millions.

First Guaranty Bancshares, Inc.

Profit Growth Continues to Advance

Despite weak Revenues in the forth quarter, company has managed to improve it's earnings per share, profits soared by 32.15 % to $0.30 per share while Revenues fell by -6.43 % to $14.44 millions, year on year.

Carey Watermark Investors Inc

Deficit Bigger Than a Year Ago, Sales are Up

Carey Watermark Investors Inc announced earnings per share of $-0.05 and Sales of $148.24 millions in the forth quarter, Company's losses widen per share, versus $0.06 eps, earned in the same quarter a year ago, although Carey Watermark Investors Inc saw it's Sales rise by 8.88 % in the same period.

Progenics Pharmaceuticals Inc

Progenics Pharmaceuticals Inc announced forth quarter operating deficit of $-14.552 millions

In the forth quarter Progenics Pharmaceuticals Inc losses widen of $-0.17 per share compare to $-0.04 a year ago and improved from $-0.30 per share from the previous quarter.

Sales declined in double digits by -16.74 % to $3.24 millions from $3.89 millions in the same quarter a year ago and sequentially Sales Tumbled by -39.1 % from $5.32 millions.

Customers Net Income grew by GS's customers Net margin grew to
37.18 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers

You need to upgrade your Flash Player

Major Competitors Stock performance

5 Days Decrease / Increase
INTL        4.3% 
MS        4.57% 
BLK        1.57% 
SCHW        3.98% 
BK        2.33% 
AIG        1.88% 
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

SRT's Profile

Stock Price

SRT's Financials

Business Description


Charts & Quotes

SRT's News


SRT's Competitors

Customers & Markets

Economic Indicators

SRT's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071